Real Science,
Real Breakthroughs
Here's the thing about aging—scientists have been trying to crack its code for decades. We actually did something about it.
How We Started
Back in the UCLA labs, our co-founder Dr. Yi Eve Sun was wrestling with a fascinating challenge. She and her team weren't content with just managing age-related diseases. They wanted to fix the root problem: old cells acting, well, old.
Working from Nobel Prize-winning research on stem cells, they discovered something remarkable. They could take your own cells and essentially teach them to be young again—no genetic tampering required.
The real test came in 2018.
Picture this: a 73-year-old woman arrives at Tongji Hospital in Shanghai. Severe rheumatoid arthritis. Osteoporosis. Wheelchair-bound. We gave her our first clinical treatment using her own rejuvenated cells.
Within months? She was walking again. Threading needles. Living her life.
That's when we knew we had something extraordinary.
What Drives Us
We see a world where getting older doesn't mean getting sicker. Where your own cells hold the key to staying healthy longer.
"Let life science benefit all mankind and greatly improve the overall health level of mankind."
Sure, that sounds ambitious. But here's what it really means—we're done with band-aid solutions. Our Prometheus cell technology goes straight to the source, fixing the cellular damage that makes us age in the first place.
This isn't science fiction. It's happening right now.
The Prometheus Protocol
Watch how we transform aged cells back to their youthful state, reversing the biological clock at the cellular level.
Our Team
United by Science, Driven by Purpose
At Celljevity, we've assembled a world-class team of scientists, clinicians, business leaders, and advisors who share a common vision: transforming human health through the power of cellular regeneration. Our multidisciplinary expertise spans molecular biology, clinical medicine, finance, and biotechnology commercialization.
Diederik van der Reijt
CEO & Chairman
Serial biotech entrepreneur and investor Diederik van der Reijt founded Celljevity (cellular rejuvenation) and co-founded NKore Biotherapeutics (immunotherapies). Leveraging his background in trading and venture capital, he aims to scale science-backed innovations and democratize access to breakthrough cellular therapies.
Connect on LinkedIn
Dr. Yi Eve Sun
Professor, UCLA
Former Deputy Director of UCLA Stem Cell Biology with 100+ publications in Cell, Nature, and Science. A pioneer in cellular reprogramming whose groundbreaking work forms the foundation of our proprietary Prometheus cell technology.
Dr. Lin Quan
Chief Scientist, IDDRC Center, UCLA School of Medicine
Clinical Director for preclinical research, focusing on Auto-rFib therapy research with expertise in cell culture and animal experiments. Dr. Quan leads our preclinical investigations for neurodegenerative disease applications.
Dr. Adeel Khan
Clinical Advisor, Regenerative Medicine
Board-certified physician and Co-founder of Minicircle, specializing in stem cell therapy and gene therapy applications. University of Ottawa medical graduate with clinical expertise in regenerative treatments. Through Eterna Health, operates international clinics focusing on cutting-edge longevity interventions and has collaborated with scientists across North America, Europe, and Asia.
Dr. Joseph Regan
Non-Executive Director
Conducted groundbreaking research mapping cancer stem cell pathways at Charite Berlin. Developed 3D tumor modeling platforms with work published in Cell Reports.
Connect on LinkedIn
Jamie Grooms
Executive Board Member
CEO of NKore Biotherapeutics, Founder of AxoGen and RTI Surgical, Jamie has led the development of multiple FDA-approved regenerative treatments and successfully guided companies to IPO.
Connect on LinkedIn
Stephen Bradley
Non-Executive Director
A former British Consul-General to Hong Kong, Stephen leverages extensive diplomatic experience across Asia to advise on cross-border consultancy and strategic development. He serves on the boards of Cenovus Energy Inc., CK Asset Holdings, and Power Assets Holdings.
Neil Bush
Senior Advisor
Neil brings 40+ years as a global business leader, specializing in cross-border investments in Asia and the Middle East. He is the Founder of the George H. W. Bush Foundation for U.S.-China Relations. Neil chairs Points of Light and the Bush School Advisory Board and holds degrees from Tulane University.
Connect on LinkedIn
Dave Bizer
Senior Investment Advisor
Co-founder of GCW Global Customised Wealth with extensive financial leadership experience. Former Managing Partner at Jasper Ridge Partners and served on Nomura's Executive Committee. Stanford Ph.D. economist with advisory roles at two U.S. Presidential administrations.
Connect on LinkedIn
Rachid Bouzouba
Senior Capital Markets Advisor
Veteran financier with 30+ years' experience who co-founded MCM Partners after leadership roles at Lehman Brothers and as Global Head of Equities at Nomura. École Polytechnique graduate now mentoring high-growth ventures in finance and technology.
Connect on LinkedIn
Rogier van Bijnen
Legal Advisor
Specializing in Asia-Pacific life sciences legal practice with focus on cross-border biotech partnerships, regulatory compliance, and IP.
Connect on LinkedIn
Shirin Azad
Co-Founder
As an author and investor in biotech talent and funding across Europe, Shirin's past roles centred around headhunting and strategy across different industries. Shirin now advises on cross-border partnerships and healthcare philanthropy, focusing on rare disease research, such as Dementia and patient advocacy.
Paul Spiegel
Strategic Advisor
International business development executive with extensive experience in Asia-Pacific markets and cross-border partnerships. Paul specializes in strategic planning and market expansion for biotechnology companies, bringing deep expertise in regulatory affairs and commercial strategy across multiple jurisdictions.
The Power of Collective Excellence
World-class scientific expertise with 100+ publications in premier journals
Proven business leadership with multiple successful biotech exits
Global network spanning the US, Europe, and Asia
Regulatory expertise across major markets
Capital markets experience from leading financial institutions
Together, we're not just advancing the science of cellular regeneration – we're building the infrastructure to bring these breakthrough therapies to patients worldwide.
At Celljevity, extraordinary people united by purpose are pioneering the future of human longevity.
The Journey So Far
The UCLA Years
UCLA labs become our playground. We crack the code on making old cells young again without changing their DNA.
The Breakthrough
That wheelchair-bound grandmother walks again. First proof our science works in real people, not just petri dishes.
The Results Pile Up
37 Alzheimer's patients keep their cognitive abilities. 56 autoimmune patients (90%!) feel real relief. 80 arthritis patients—two-thirds get their mobility back.
Global Expansion
We're navigating regulatory approvals and taking this global. The science works. Now we scale it.
What We Stand For
Real Evidence, Real Results
We don't make claims we can't back up. Every treatment gets put through its paces—including single-cell RNA sequencing that shows exactly what's happening at the molecular level. No guesswork. Just data.
Your Safety Comes First
Using your own cells means zero rejection risk. Our GMP-certified facilities follow protocols that would make a Swiss watchmaker jealous. We're meticulous because we have to be.
Doing Things Right
International ethical standards aren't suggestions to us—they're requirements. Full transparency. WHO registry compliance. If we wouldn't want it for our families, we won't do it to yours.
Science for Everyone
Yes, we're pushing boundaries. But breakthrough treatments shouldn't be luxury goods. We're building ways to get these therapies to everyone who needs them.
Partners Who Get It
Great science doesn't happen in isolation. We work with:
UCLA Medical Center
Where it all started, and still our research home
Tongji University & Hospital
Running world-class trials in China
Research Centers Worldwide
Because good ideas don't respect borders
Yimin Biotechnology Shanghai
Turning lab breakthroughs into real treatments
Where We're Headed
Look, we're not just trying to add years to life. We want those years to count.
Imagine a future where cellular regeneration is as routine as antibiotics. Where aging becomes optional, not inevitable. That's not fantasy—that's our roadmap.
Ready to be part of this?
Whether you're a patient who needs answers, a researcher with ideas, an investor who sees the potential, or a healthcare provider who wants to offer something better—we should talk.
Because together, we're not just making people live longer.
We're making sure they want to.